Prospects of genome editing using CRISPR/CAS or how to master genetic scissors. Nobel Prize in Chemistry 2020 by S. V. Komisarenko, S. I. Romaniuk

Subjects: Get full text

RNA-programmed genome editing in human cells by Martin Jinek, Alexandra East, Aaron Cheng, Steven Lin, Enbo Ma, Jennifer Doudna

Get full text

Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination by Rahul K. Suryawanshi, Taha Y. Taha, Maria McCavitt-Malvido, Ines Silva, Mir M. Khalid, Abdullah M. Syed, Irene P. Chen, Prachi Saldhi, Bharath Sreekumar, Mauricio Montano, Kafaya Foresythe, Takako Tabata, G. Renuka Kumar, Alicia Sotomayor-Gonzalez, Venice Servellita, Amelia Gliwa, Jenny Nguyen, Noah Kojima, Teresa Arellanor, Aallyah Bussanich, Victoria Hess, Maria Shacreaw, Lauren Lopez, Matthew Brobeck, Fred Turner, Yuzhu Wang, Sydney Ghazarian, Gregg Davis, Diviana Rodriguez, Jennifer Doudna, Lee Spraggon, Charles Y. Chiu, Melanie Ott

Get full text

Addressing Conflicts of Interest and Conflicts of Commitment in Public Advocacy and Policy Making on CRISPR/Cas-Based Human Genome Editing by Alexander Christian

“…Leading experts on CRISPR/Cas-based genome editing—such as 2020 Nobel laureates Jennifer Doudna and Emmanuelle Charpentier—are not only renowned specialists in their fields, but also public advocates for upcoming regulatory frameworks on CRISPR/Cas. …”
Get full text